Extends the offer period for the voluntary offer to acquire weifa
·Karo Pharma AB has decided that the previously announced voluntary cash offer to acquire Weifa ASA will be extended by one week to 3 October 2017 at 16.30 (CEST) ·As of today Karo Pharma has received acceptances under the Voluntary Offer for a total of 32 294 687 shares representing approximately 88.55 % of the total shares in Weifa on a fully diluted basis. ·Except for the extension of the offer period, all other terms and conditions of the Voluntary Offer remain unchanged. ·Karo Pharma maintains its right to further extend the offer period with one more week in